In this context, we analyzed the expression of the most potent pro-angiogenic factor VEGFα and its counter player angiostatin in the aortic rings of the Fabry R301Q transgenic/KO mouse model and compared this with the expression in the serum of patients with Fabry’s disease and healthy controls. This evidence concerns the gene VEGFA and Fabry disease.